Abstract
CONTEXT: Exogenous insulin is reported to have both vasodilatory and vasoconstrictive effects on the microvasculature. Little is known about the associations of long-term endogenous insulin exposure with microvasculature.
OBJECTIVE: To test the hypothesis that long-term exposure to high insulin levels in childhood and adulthood is associated with adverse changes in retinal microvasculature in adulthood in a population without diabetes.
METHODS: We analyzed data derived from the longitudinal Cardiovascular Risk in Young Finns Study (YFS). The first cross-sectional study was conducted in 1980, and participants were followed for 31 years from childhood to adulthood with frequent follow-up visits. Fundus photos were taken in 2011, and microvascular outcome measures were derived in participants at the age of 34-49 years (n=1684). After exclusion of individuals with diabetes or missing insulin measures, 1166 participants formed the population of the present study. Cumulative exposure as the area under the curve (AUC) for adulthood (10-year exposure between 2001 and 2011), and childhood (exposure between ages 6-18 years) insulin and other cardiovascular risk factors were determined. Additionally, adulthood and childhood cumulative AUCs were summarized to construct life-long AUCs.
RESULTS: Higher adulthood, childhood and life-long exposure for cumulative insulin was associated with decreased retinal arteriolar diameter when adjusted for age and sex, and further for cumulative conventional cardiovascular risk factors.
CONCLUSIONS: Cumulative childhood, adulthood and life-long insulin are associated with decreased retinal arteriolar diameter in adulthood in a population of participants without diabetes, independently of conventional cardiovascular risk factors.
| Original language | English |
|---|---|
| Pages (from-to) | e3085–e3092 |
| Number of pages | 8 |
| Journal | Journal of Clinical Endocrinology and Metabolism |
| Volume | 110 |
| Issue number | 9 |
| Early online date | 11 Dec 2024 |
| DOIs | |
| Publication status | Published - 1 Sept 2025 |
Bibliographical note
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), whichpermits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Funding
The Young Finns Study has been financially supported by the Academy of Finland: grants 356405, 322098, 286284, 134309 (Eye), 126925, 121584, 124282, 129378 (Salve), 117797 (Gendi), and 141071 (Skidi); the Social Insurance Institution of Finland; Competitive State Research Financing of the Expert Responsibility area of Kuopio, Tampere and Turku University Hospitals (grant X51001); Juho Vainio Foundation; Paavo Nurmi Foundation; Finnish Foundation for Cardiovascular Research; Finnish Cultural Foundation; Sigrid Juselius Foundation; Tampere Tuberculosis Foundation; Emil Aaltonen Foundation; Yrj\u00F6 Jahnsson Foundation; Signe and Ane Gyllenberg Foundation; Diabetes Research Foundation of Finnish Diabetes Association; EU Horizon 2020 (grant 755320 for TAXINOMISIS and grant 848146 for To Aition); European Research Council (grant 742927 for MULTIEPIGEN project); Tampere University Hospital Supporting Foundation; Finnish Society of Clinical Chemistry; the Cancer Foundation Finland; pBETTER4U_EU (Preventing obesity through Biologically and bEhaviorally Tailored inTERventions for you; project number: 101080117); CVDLink (EU grant nro. 101137278), and the Jane and Aatos Erkko Foundation. K.P. is supported by an Academy of Finland research fellowship (322112).
| Funders | Funder number |
|---|---|
| Tampereen Tuberkuloosisäätiö | |
| Paavo Nurmen Säätiö | |
| Jane ja Aatos Erkon Säätiö | |
| Signe ja Ane Gyllenbergin Säätiö | |
| Suomen Kulttuurirahasto | |
| Suomen kliinisen kemian yhdistys | |
| Juho Vainion Säätiö | |
| Emil Aaltosen Säätiö | |
| Diabetestutkimussäätiö | |
| Syöpäsäätiö | |
| Sydäntutkimussäätiö | |
| Tampere University Hospital | |
| Yrjö Jahnssonin Säätiö | |
| Sigrid Juséliuksen Säätiö | |
| Horizon Europe | 848146, 755320 |
| Turku University Hospital | X51001 |
| Research Council of Finland | 126925, 322098, 129378, 121584, 117797, 141071, 356405, 286284, 134309, 124282 |
| European Research Council | 742927 |
Keywords
- insulin
- microvascular changes
- arterioles
- retina
- lifespan